Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial - Li, Xiaoke; Zhou, Daqiao; Chi, Xiaoling; Li, Qin; Wang, Li; Lu, Bingjiu; Mao, Dewen; Wu, Qikai; Wang, Xianbo; Zhang, Mingxiang; Xue, Jingdong; Li, Yong; et al. (Hepatology international, 2020)
Keywords: Adverse events; Antigens; Antiviral Agents - therapeutic use; Antiviral drugs; Clinical trials; Colorectal Surgery; Deoxyribonucleic acid; DNA; DNA, Viral; Drug Combinations; Drugs, Chinese Herbal - therapeutic use; Enzymes; Granular materials; Guanine - analogs & derivatives; Guanine - therapeutic use; Hepatitis; Hepatitis B; Hepatitis B e antigen; Hepatitis B e Antigens; Hepatitis B surface antigen; Hepatitis B virus - genetics; Hepatitis B, Chronic - drug therapy; Hepatology; Herbal medicine; Humans; Liver; Medicine; Medicine & Public Health; Nucleoside analogs; Original Article; Placebos; Statistical analysis; Surgery; Therapy; Traditional Chinese medicine; Treatment Outcome; Traditional Chinese medicine; Tiao-gan-yi-pi granule; Chronic hepatitis B; Tiao-gan-jian-pi-jie-du granule